Literature DB >> 7915483

Fumaric acid esters (FAEs) suppress CD 15- and ODP 4-positive cells in psoriasis.

M Bacharach-Buhles1, F M Pawlak, U Matthes, R K Joshi, P Altmeyer.   

Abstract

A histological-immunohistological study was conducted to investigate the effect of systemically administered fumaric acid esters (FAEs) on epidermal thickness and composition of the inflammatory infiltrate in psoriatic plaques. The very first effect of systemic therapy with FAEs is the disappearance of CD 15-positive cells in the beneath the epidermis, accompanied by a significant reduction in T-helper cells beneath the epidermis, pointing to an immunosuppressive effect. This is followed after some delay by a reduction in acanthosis and hyperkeratosis. The reduction in infiltrating T-lymphocytes corresponds to that seen after systemic or intralesional therapy with cyclosporin. However, the normalization of the psoriatic plaques takes longer under the influence of FAEs than under cyclosporin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7915483

Source DB:  PubMed          Journal:  Acta Derm Venereol Suppl (Stockh)        ISSN: 0365-8341


  7 in total

1.  In reply.

Authors:  Christos C Zouboulis
Journal:  Dtsch Arztebl Int       Date:  2015-03-27       Impact factor: 5.594

2.  Improvement of herpetic stromal keratitis with fumaric acid derivate is associated with systemic induction of T helper 2 cytokines.

Authors:  A Heiligenhaus; H Li; A Schmitz; S Wasmuth; D Bauer
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

3.  Influence of dimethylfumarate on experimental HSV-1 necrotizing keratitis.

Authors:  A Heiligenhaus; H Li; S Wasmuth; D Bauer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-06       Impact factor: 3.117

4.  Fumaric Acid and its esters: an emerging treatment for multiple sclerosis.

Authors:  D Moharregh-Khiabani; R A Linker; R Gold; M Stangel
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

5.  [Successful treatment of skin and lung sarcoidosis with fumaric acid ester].

Authors:  R Gutzmer; A Kapp; T Werfel
Journal:  Hautarzt       Date:  2004-06       Impact factor: 0.751

Review 6.  Utilization of Dimethyl Fumarate and Related Molecules for Treatment of Multiple Sclerosis, Cancer, and Other Diseases.

Authors:  Zaidoon Al-Jaderi; Azzam A Maghazachi
Journal:  Front Immunol       Date:  2016-07-22       Impact factor: 7.561

7.  Fumaric acid esters in dermatology.

Authors:  Uwe Wollina
Journal:  Indian Dermatol Online J       Date:  2011-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.